CIAM
FLGT icon

Caitong International Asset Management’s Fulgent Genetics FLGT Stock Holding History

Caitong International Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,834
Closed -$48.2K – 2739
2025
Q4 		$48.2K Buy
1,834
+1,251
+215% +$32.5K 0.01% 713
2025
Q3 		$13.2K Buy
583
+203
+53% +$4.18K 0.01% 917
2025
Q2 		$7.55K Buy
380
+223
+142% +$4.35K 0.01% 838
2025
Q1 		$2.65K Buy
+157
New +$2.67K ﹤0.01% 1238

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Caitong International Asset Management's FLGT Position: Q1 2026 in Review

Caitong International Asset Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 1,834 shares — an estimated $48.2K sold.

Caitong International Asset Management first reported a position in FLGT in Q1 2025 and held it in 4 quarters. The position peaked at $48.2K in Q4 2025. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Caitong International Asset Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,834 Fulgent Genetics shares in Q1 2026, an estimated $48.2K.
  • Caitong International Asset Management first reported a position in Fulgent Genetics in Q1 2025 and held it in 4 quarters.
  • Caitong International Asset Management's Fulgent Genetics position peaked at $48.2K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.